These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 18006760)
1. Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma. Aoki H; Yokoyama T; Fujiwara K; Tari AM; Sawaya R; Suki D; Hess KR; Aldape KD; Kondo S; Kumar R; Kondo Y Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6603-9. PubMed ID: 18006760 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of p21-activated kinase 1 by progestin and its increased expression in the eutopic endometrium of women with endometriosis. Kim SH; Lee HW; Kim YH; Koo YH; Chae HD; Kim CH; Lee PR; Kang BM Hum Reprod; 2009 May; 24(5):1133-41. PubMed ID: 19168872 [TBL] [Abstract][Full Text] [Related]
3. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma. Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324 [TBL] [Abstract][Full Text] [Related]
4. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment. Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313 [TBL] [Abstract][Full Text] [Related]
5. Ectopic doublecortin gene expression suppresses the malignant phenotype in glioblastoma cells. Santra M; Zhang X; Santra S; Jiang F; Chopp M Cancer Res; 2006 Dec; 66(24):11726-35. PubMed ID: 17178868 [TBL] [Abstract][Full Text] [Related]
6. P21-activated protein kinase 1 is overexpressed in gastric cancer and induces cancer metastasis. Li LH; Luo Q; Zheng MH; Pan C; Wu GY; Lu YZ; Feng B; Chen XH; Liu BY Oncol Rep; 2012 May; 27(5):1435-42. PubMed ID: 22293972 [TBL] [Abstract][Full Text] [Related]
7. c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme. Liu W; Fu Y; Xu S; Ding F; Zhao G; Zhang K; Du C; Pang B; Pang Q J Clin Neurosci; 2011 Jan; 18(1):119-21. PubMed ID: 20832323 [TBL] [Abstract][Full Text] [Related]
8. miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. Fowler A; Thomson D; Giles K; Maleki S; Mreich E; Wheeler H; Leedman P; Biggs M; Cook R; Little N; Robinson B; McDonald K Eur J Cancer; 2011 Apr; 47(6):953-63. PubMed ID: 21196113 [TBL] [Abstract][Full Text] [Related]
9. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation. Siu MK; Kong DS; Ngai SY; Chan HY; Jiang L; Wong ES; Liu SS; Chan KK; Ngan HY; Cheung AN PLoS One; 2015; 10(7):e0133467. PubMed ID: 26218748 [TBL] [Abstract][Full Text] [Related]
10. Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue. Lama G; Mangiola A; Anile C; Sabatino G; De Bonis P; Lauriola L; Giannitelli C; La Torre G; Jhanwar-Uniyal M; Sica G; Maira G Int J Oncol; 2007 Jun; 30(6):1333-42. PubMed ID: 17487353 [TBL] [Abstract][Full Text] [Related]
11. Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells. Guo H; Gu F; Li W; Zhang B; Niu R; Fu L; Zhang N; Ma Y J Neurochem; 2009 Apr; 109(1):203-13. PubMed ID: 19187446 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of p21-activated kinase 1 promotes endometrial cancer progression. Lu W; Qu JJ; Li BL; Lu C; Yan Q; Wu XM; Chen XY; Wan XP Oncol Rep; 2013 Apr; 29(4):1547-55. PubMed ID: 23338047 [TBL] [Abstract][Full Text] [Related]
13. The morphology of perinecrotic tumor cell nuclei in glioblastomas shows a significant relationship with survival time. Nafe R; Franz K; Schlote W; Schneider B Oncol Rep; 2006 Sep; 16(3):555-62. PubMed ID: 16865255 [TBL] [Abstract][Full Text] [Related]
14. Morphology of tumor cell nuclei is significantly related with survival time of patients with glioblastomas. Nafe R; Franz K; Schlote W; Schneider B Clin Cancer Res; 2005 Mar; 11(6):2141-8. PubMed ID: 15788659 [TBL] [Abstract][Full Text] [Related]
15. Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications. Mangiola A; Lama G; Giannitelli C; De Bonis P; Anile C; Lauriola L; La Torre G; Sabatino G; Maira G; Jhanwar-Uniyal M; Sica G Clin Cancer Res; 2007 Dec; 13(23):6970-7. PubMed ID: 18056172 [TBL] [Abstract][Full Text] [Related]
16. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis. Mikami S; Oya M; Shimoda M; Mizuno R; Ishida M; Kosaka T; Mukai M; Nakajima M; Okada Y Clin Cancer Res; 2008 Oct; 14(19):6055-61. PubMed ID: 18809970 [TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme. Chang CY; Li MC; Liao SL; Huang YL; Shen CC; Pan HC J Clin Neurosci; 2005 Nov; 12(8):930-3. PubMed ID: 16326273 [TBL] [Abstract][Full Text] [Related]
18. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion. Siu MK; Wong ES; Chan HY; Kong DS; Woo NW; Tam KF; Ngan HY; Chan QK; Chan DC; Chan KY; Cheung AN Int J Cancer; 2010 Jul; 127(1):21-31. PubMed ID: 19876919 [TBL] [Abstract][Full Text] [Related]
19. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients. Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246 [TBL] [Abstract][Full Text] [Related]
20. Hypericin uptake: a prognostic marker for survival in high-grade glioma. Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]